CHINA BCT PHARMACY GROUP, INC. Operating Expenses
CHINA BCT PHARMACY GROUP, INC. reported Operating Expenses of $5.22 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2013-05-20
- CHINA BCT PHARMACY GROUP, INC. operating expenses for the quarter ending 2013-03-31 was $5.22M, a 19.30% increase year-over-year.
- CHINA BCT PHARMACY GROUP, INC. operating expenses for the quarter ending 2012-12-31 was $5.19M, a 18.16% decline year-over-year.
- CHINA BCT PHARMACY GROUP, INC. operating expenses for the quarter ending 2012-09-30 was $4.92M, a 27.98% increase year-over-year.
- CHINA BCT PHARMACY GROUP, INC. operating expenses for the quarter ending 2012-06-30 was $4.81M, a 7.86% increase year-over-year.
- CHINA BCT PHARMACY GROUP, INC. operating expenses for fiscal 2012 was $19.30M, a 1.64% decline from fiscal 2011.
- CHINA BCT PHARMACY GROUP, INC. operating expenses for fiscal 2011 was $19.62M, a 45.88% increase from fiscal 2010.
- CHINA BCT PHARMACY GROUP, INC. operating expenses for fiscal 2010 was $13.45M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2013-03-31 | $5.22M 10-Q · filed 2013-05-20 | $10.41M derived: sum of 2 quarters · filed 2013-05-20 | $15.33M derived: sum of 3 quarters · filed 2013-05-20 | $20.14M derived: sum of 4 quarters · filed 2013-05-20 |
| 2012-12-31 | $5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15 | $10.11M derived: sum of 2 quarters · filed 2013-04-15 | $14.92M derived: sum of 3 quarters · filed 2013-04-15 | $19.30M 10-K · filed 2013-04-15 |
| 2012-09-30 | $4.92M 10-Q · filed 2012-11-15 | $9.73M derived: sum of 2 quarters · filed 2012-11-15 | $14.11M 10-Q · filed 2012-11-15 | $20.45M derived: sum of 4 quarters · filed 2013-05-20 |
| 2012-06-30 | $4.81M 10-Q · filed 2012-08-17 | $9.18M 10-Q · filed 2012-08-17 | $15.52M derived: sum of 3 quarters · filed 2013-05-20 | $19.37M derived: sum of 4 quarters · filed 2013-05-20 |
| 2012-03-31 | $4.38M 10-Q · filed 2013-05-20 | $10.72M derived: sum of 2 quarters · filed 2013-05-20 | $14.56M derived: sum of 3 quarters · filed 2013-05-20 | $19.02M derived: sum of 4 quarters · filed 2013-05-20 |
| 2011-12-31 | $6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15 | $10.19M derived: sum of 2 quarters · filed 2013-04-15 | $14.64M derived: sum of 3 quarters · filed 2013-04-15 | $19.62M 10-K · filed 2013-04-15 |
| 2011-09-30 | $3.85M 10-Q · filed 2012-11-15 | $8.30M derived: sum of 2 quarters · filed 2012-11-15 | $13.28M 10-Q · filed 2012-11-15 | $17.95M derived: sum of 4 quarters · filed 2012-11-15 |
| 2011-06-30 | $4.46M 10-Q · filed 2012-08-17 | $9.43M 10-Q · filed 2012-08-17 | $14.10M derived: sum of 3 quarters · filed 2012-08-17 | $17.86M derived: sum of 4 quarters · filed 2012-08-17 |
| 2011-03-31 | $4.98M 10-Q · filed 2012-05-21 | $9.64M derived: sum of 2 quarters · filed 2012-06-12 | $13.40M derived: sum of 3 quarters · filed 2012-06-12 | $15.75M derived: sum of 4 quarters · filed 2012-06-12 |
| 2010-12-31 | $4.67M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-06-12 | $8.42M derived: sum of 2 quarters · filed 2012-06-12 | $10.78M derived: sum of 3 quarters · filed 2012-06-12 | $13.45M 10-K/A · filed 2012-06-12 |
| 2010-09-30 | $3.76M 10-Q · filed 2011-11-14 | $6.11M derived: sum of 2 quarters · filed 2011-11-14 | $8.78M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $2.35M 10-Q · filed 2011-08-15 | $5.02M 10-Q · filed 2011-08-15 |